Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H
Department of Psychiatry, University of Münster, Germany.
Neuroreport. 2000 Oct 20;11(15):3385-8. doi: 10.1097/00001756-200010200-00024.
Recent findings have strengthened the hypothesis that immunological dysfunctions may contribute towards the multifactorial pathogenesis of schizophrenia. The validity of these findings is questioned by the fact that most studied subjects have received potentially immunomodulatory medication upon investigation. In order to rule out such confounding effects, 24 initially unmedicated acutely ill schizophrenic patients were studied immunologically and psychiatrically (PANSS) before and during 4 weeks of neuroleptic treatment. The production of IFN-gamma was decreased upon admission and after 2 weeks of treatment compared to matched healthy controls. No differences in IL-2 and IFN-gamma production between unmedicated and medicated states were observed. These results do not support the notion that neuroleptic medication in vivo might influence TH1 cytokine production in schizophrenia.
最近的研究结果强化了一种假说,即免疫功能障碍可能在精神分裂症的多因素发病机制中起作用。然而,由于大多数研究对象在调查时已接受了可能具有免疫调节作用的药物治疗,这些研究结果的有效性受到质疑。为了排除这种混杂效应,对24名最初未接受药物治疗的急性精神分裂症患者在接受抗精神病药物治疗的4周内及治疗前进行了免疫学和精神病学(阳性和阴性症状量表)研究。与匹配的健康对照组相比,入院时和治疗2周后干扰素-γ的产生减少。未观察到未用药状态和用药状态之间白细胞介素-2和干扰素-γ产生的差异。这些结果不支持抗精神病药物在体内可能影响精神分裂症患者TH1细胞因子产生的观点。